Panjang
Update: wedge forming!
This is an update from my previous post and I believe the fundamentals are stronger than ever and technicals are starting to line up.
This is currently trading at a 30 m marketcap yet q1 revenue is expected to hit more than 17m.
Their diagnostic tests yield them a 55% margin
PP at 0.25 for 5 million cash.
They have plans on setting up a contract with JNJ to administer their vaccines as it's a one shot vaccine that does not require the refrigeration like the other ones, making ideal for rural areas.
cnn.com/world/live-news/coronavirus-pandemic-vaccine-updates-04-23-21/h_c8aa1a02c9ed141ad8125148232ddacc
CDC advisor has just put his stamp of approval on the jnj vaccine .
So then where are we now?
1)We will have continuous covid testing, thought admittedly it may slow down.
2) We can sell home self-testing kits
3) HRSA funding in place, allowing uninsured individuals to get testing for free.
4)A strong Q1 is expected, but not priced in
5)We are waiting for Blowfish results in a week or 2. I highly recommend you watch this video for a better understanding of why this is a very exciting trial.
drive.google.com/file/d/1kPpaCha6WcNxC24DJhNk4AxZ7Iqatklu/view
6) All of this covid stuff is just one side of their business as they will eventually pivot to tele diagnostics, and by that time, they will likely have an extremely strong balance sheet.
Here we have an extremely undervalued company with many vectors of revenue with many catalysts coming up.
For technical analysis:
Here we are forming a falling wedge, which is considered a bullish pattern and we are also approaching an important support zone.
On the indicators we can see there is bullish divergence forming.
Many factors coming together to point towards we are very near the bottom.
This is currently trading at a 30 m marketcap yet q1 revenue is expected to hit more than 17m.
Their diagnostic tests yield them a 55% margin
PP at 0.25 for 5 million cash.
They have plans on setting up a contract with JNJ to administer their vaccines as it's a one shot vaccine that does not require the refrigeration like the other ones, making ideal for rural areas.
cnn.com/world/live-news/coronavirus-pandemic-vaccine-updates-04-23-21/h_c8aa1a02c9ed141ad8125148232ddacc
CDC advisor has just put his stamp of approval on the jnj vaccine .
So then where are we now?
1)We will have continuous covid testing, thought admittedly it may slow down.
2) We can sell home self-testing kits
3) HRSA funding in place, allowing uninsured individuals to get testing for free.
4)A strong Q1 is expected, but not priced in
5)We are waiting for Blowfish results in a week or 2. I highly recommend you watch this video for a better understanding of why this is a very exciting trial.
drive.google.com/file/d/1kPpaCha6WcNxC24DJhNk4AxZ7Iqatklu/view
6) All of this covid stuff is just one side of their business as they will eventually pivot to tele diagnostics, and by that time, they will likely have an extremely strong balance sheet.
Here we have an extremely undervalued company with many vectors of revenue with many catalysts coming up.
For technical analysis:
Here we are forming a falling wedge, which is considered a bullish pattern and we are also approaching an important support zone.
On the indicators we can see there is bullish divergence forming.
Many factors coming together to point towards we are very near the bottom.
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.